…
Sumitomo Chemical India Limited engages in the manufacture and sale of household and public health insecticides, agricultural pesticides, and animal nutrition products in India and internationally. It also offers crop protection products, such as insecticides, herbicides, fungicides, and miticides; animal nutrition; plant nutrition and plant growth regulators; fumigants and rodenticides; weedicides; and biological products. The company was incorporated in 2000 and is headquartered in Mumbai, India. Sumitomo Chemical India Limited is a subsidiary of Sumitomo Chemical Company Limited.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Income before tax | 6802.35M | 5029.48M | 6541.76M | 5757.31M | 4532.99M |
| Minority interest | -9.47M | -2.03M | 0.00M | 0.13M | 1.01M |
| Net income | 5054.96M | 3695.41M | 5022.09M | 4235.58M | 3454.06M |
| Selling general administrative | 2697.33M | 2516.04M | 187.57M | 156.78M | 291.84M |
| Selling and marketing expenses | 465.12M | 387.14M | 1206.00M | 1306.68M | 1057.00M |
| Gross profit | 12704.48M | 10485.95M | 12403.39M | 11236.13M | 9660.16M |
| Reconciled depreciation | 660.58M | 621.89M | 518.78M | 448.14M | 465.83M |
| Ebit | 5660.67M | 4123.98M | 6595.70M | 5653.05M | 4705.07M |
| Ebitda | 6095.42M | 4532.87M | 7114.48M | 6101.19M | 5170.90M |
| Depreciation and amortization | 434.75M | 408.89M | 518.78M | 448.14M | 465.83M |
| Operating income | 9526.22M | 7569.35M | 6148.64M | 5566.20M | 4435.62M |
| Other operating expenses | 21959.02M | 20870.12M | 28962.49M | 24819.01M | 21622.69M |
| Interest expense | 65.93M | 56.93M | 53.94M | 47.18M | 40.97M |
| Tax provision | 1737.92M | 1332.04M | 1519.67M | 1521.86M | 1078.93M |
| Interest income | 1144.69M | 589.97M | 53.94M | 61.67M | 55.55M |
| Net interest income | -58.60M | -51.07M | -53.94M | -61.67M | -55.55M |
| Income tax expense | 1737.92M | 1332.04M | 1519.67M | 1521.86M | 1078.93M |
| Total revenue | 31485.24M | 28439.47M | 35109.68M | 30403.19M | 26277.08M |
| Total operating expenses | 3178.26M | 2916.60M | 6256.20M | 5651.95M | 5005.77M |
| Cost of revenue | 18780.76M | 17953.52M | 22706.29M | 19167.06M | 16616.92M |
| Total other income expense net | -2723.87M | -2539.87M | 393.12M | 191.11M | 97.37M |
| Net income from continuing ops | 5064.43M | 3697.44M | 5022.09M | 4235.45M | 3454.06M |
| Net income applicable to common shares | 5054.96M | 3695.41M | 5022.09M | 4235.58M | 3454.06M |
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Total assets | 39644.28M | 33132.68M | 33691.12M | 30096.25M | 26700.81M |
| Intangible assets | 257.85M | 247.66M | 215.53M | 184.55M | 105.73M |
| Other current assets | 1720.19M | 4494.34M | 1261.49M | 0.01M | 1503.41M |
| Total liab | 10593.48M | 8687.26M | 9873.30M | 10824.13M | 11287.80M |
| Total stockholder equity | 29011.45M | 24415.67M | 23817.80M | 19272.10M | 15412.00M |
| Deferred long term liab | - | - | - | 6.67M | 4.99M |
| Other current liab | 4567.00M | 3149.65M | 512.24M | 797.65M | 1081.92M |
| Common stock | 4991.46M | 4991.46M | 4991.46M | 4991.46M | 4991.46M |
| Capital stock | 4991.46M | 4991.46M | 4991.46M | 4991.46M | 4991.46M |
| Retained earnings | 3621.16M | 2274.64M | 1675.21M | 1631.94M | 1517.90M |
| Other liab | - | - | - | 362.49M | 342.44M |
| Good will | 604.41M | 622.46M | - | - | - |
| Other assets | 120.43M | 85.45M | 435.92M | 385.67M | 425.59M |
| Cash | 382.33M | 466.36M | 468.91M | 572.46M | 2133.06M |
| Cash and equivalents | 148.50M | 112.70M | 236.80M | 201.30M | 1542.50M |
| Total current liabilities | 9651.78M | 8007.03M | 9333.96M | 10214.45M | 10792.03M |
| Current deferred revenue | - | 434.25M | 3753.33M | 4116.26M | 3553.80M |
| Net debt | 91.03M | -163.87M | -129.19M | -196.62M | -1806.71M |
| Short term debt | 191.12M | 117.36M | 162.27M | 128.65M | 173.02M |
| Short long term debt | 0.00M | 5.06M | - | - | - |
| Short long term debt total | 518.93M | 302.49M | 339.72M | 375.84M | 326.35M |
| Other stockholder equity | 2350.60M | 17081.70M | 17151.13M | 12648.70M | 8902.64M |
| Property plant equipment | 4986.04M | 4981.88M | 4794.65M | 4071.17M | 3129.66M |
| Total current assets | 30203.04M | 26728.60M | 27879.46M | 25220.29M | 23043.33M |
| Net tangible assets | - | - | - | 19094.22M | 15311.26M |
| Short term investments | 12211.43M | 3457.42M | 7796.36M | 5181.61M | 3190.04M |
| Net receivables | 8852.48M | 7219.48M | 9516.56M | 8487.61M | 8494.03M |
| Inventory | 7036.61M | 6104.12M | 8886.97M | 9377.61M | 7543.63M |
| Accounts payable | 4893.66M | 4300.49M | 4906.12M | 5171.89M | 5983.29M |
| Accumulated other comprehensive income | 18048.23M | 67.87M | - | - | - |
| Non currrent assets other | 523.96M | 405.42M | 86.90M | 95.27M | 175.66M |
| Non current assets total | 9441.24M | 6404.08M | 5811.66M | 4875.96M | 3657.48M |
| Capital lease obligations | 518.93M | 297.43M | 339.72M | 375.84M | 326.35M |
| Long term debt total | 327.81M | 185.13M | 177.45M | 247.19M | 153.33M |
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Investments | -3920.59M | -4317.18M | -3271.95M | -1836.35M | -2247.85M |
| Change to liabilities | - | - | - | -756.47M | 1083.92M |
| Total cashflows from investing activities | -4570.40M | -4203.78M | -3271.95M | -2902.03M | -2576.72M |
| Net borrowings | -5.06M | -53.48M | - | -211.71M | -180.91M |
| Total cash from financing activities | -679.20M | -3370.49M | -725.45M | -626.38M | -470.64M |
| Change to operating activities | - | - | - | 163.39M | 1024.20M |
| Net income | 5054.96M | 3695.41M | 6541.76M | 5757.31M | 4532.99M |
| Change in cash | -44.58M | -2.55M | -103.55M | -1310.60M | 1206.92M |
| Begin period cash flow | 472.48M | 468.91M | 572.46M | 1883.06M | 926.14M |
| End period cash flow | 427.90M | 466.36M | 468.91M | 572.46M | 2133.06M |
| Total cash from operating activities | 5165.57M | 7571.72M | 3893.85M | 2217.81M | 4254.28M |
| Depreciation | 660.58M | 621.89M | 518.78M | 448.14M | 465.83M |
| Other cashflows from investing activities | -3626.04M | 480.44M | -2073.11M | 58.88M | 99.35M |
| Dividends paid | 440.28M | 3098.16M | -499.36M | -400.18M | -275.15M |
| Change to inventory | -938.33M | 2817.42M | 490.65M | -1833.99M | -1663.59M |
| Change to account receivables | -692.52M | 2138.86M | -1233.94M | -149.25M | -188.76M |
| Other cashflows from financing activities | -233.86M | -218.85M | -15.42M | -14.49M | -14.58M |
| Change to netincome | - | - | - | 110.41M | 78.62M |
| Capital expenditures | 294.55M | 637.43M | 1198.84M | 1135.19M | 432.64M |
| Change in working capital | -180.46M | 4533.68M | -1351.66M | -2576.32M | 255.77M |
| Other non cash items | -369.51M | -1279.26M | -1815.03M | -1411.32M | -1000.31M |
| Free cash flow | 4871.02M | 6934.29M | 2695.01M | 1082.62M | 3821.64M |
Sector: Basic Materials Industry: Agricultural Inputs
|
Stock Name
|
Change
(INR) |
Price
(INR) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| SUMICHEM Sumitomo Chemical India Limited |
- -% |
328.95 | 41.43 | - | 6.81 | 7.18 | 6.51 | 26.60 |
| UPL UPL Limited |
- -% |
534.90 | 30.63 | 26.45 | 1.41 | 2.13 | 1.96 | 11.16 |
| COROMANDEL Coromandel International Limited |
- -% |
1824.00 | 27.92 | - | 2.34 | 5.61 | 3.20 | 17.09 |
| FACT Fertilizers and Chemicals Travancore Limited |
-8.45 1.11% |
751.20 | 567.61 | - | 12.34 | 41.13 | 18.86 | 139.84 |
| PIIND PI Industries Limited |
- -% |
1735.00 | 32.51 | 46.51 | 6.60 | 4.60 | 6.25 | 19.62 |
Sumitomo Chemical India Limited engages in the manufacture and sale of household and public health insecticides, agricultural pesticides, and animal nutrition products in India and internationally. It also offers crop protection products, such as insecticides, herbicides, fungicides, and miticides; animal nutrition; plant nutrition and plant growth regulators; fumigants and rodenticides; weedicides; and biological products. The company was incorporated in 2000 and is headquartered in Mumbai, India. Sumitomo Chemical India Limited is a subsidiary of Sumitomo Chemical Company Limited.
13/14, Aradhana Industrial Development Corporation, Mumbai, India, 400063
91 22 4252 2200
1646
| Name | Title | Year Born |
|---|---|---|
| Mr. Chetan Shantilal Shah | MD & Exec. Director | 1954 |
| Mr. Anil S. Nawal | Chief Financial Officer | 1966 |
| Mr. Pravin D. Desai | VP of Legal, Compliance Officer & Company Sec. | NA |
| Mr. Sushil Champaklal Marfatia | Exec. Director | 1951 |
| Kunal Suresh Mittal | Sr. VP of Planning & Coordination Office | 1984 |
| Mr. Suresh Ramachandran | Chief Commercial Officer | 1970 |
| Kalpesh Patel | VP of Sales & Marketing | 1968 |
| Pankaj Garara | VP of Sales & Marketing | 1969 |
| Gaganpreet Singh | VP of Sales & Marketing | 1974 |
| Mr. Maddika Nagarjuna Reddy | Associate VP- Sales & Marketing | 1967 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.